Fortune Brands Home (NYSE:FBHS) reported quarterly earnings of $1.79 per share which beat the analyst consensus estimate of $1.72 by 4.07 percent. This is a 20.13 percent increase over earnings of $1.49 per share from the same period last year.
Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 For Prader-Willi Syndrome
-- Acadia acquired Levo Therapeutics and worldwide rights to ACP-101 in June 2022-- ACP-101 (intranasal carbetocin) is a selective oxytocin-receptor agonist for the treatment of hyperphagia in Prader-Willi syndrome--